Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSALKA: Rosuvastatin PK/PD in HIV Patients on Lopinavir/Ritonavir
NCT00184951Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2004
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of rosuvastatin in hyperlipidemia, sponsored by Radboud University Medical Center. Primary endpoint: Pharmacokinetics at 12 weeks. Started Apr 2004; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00184951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184951.